{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:53:01Z","timestamp":1793184781268,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Traditional Chinese medicines (TCMs) have important therapeutic value in long-term clinical practice. However, because TCMs contain diverse ingredients and have complex effects on the human body, the molecular mechanisms of TCMs are poorly understood. In this work, we determined the gene expression profiles of cells in response to TCM components to investigate TCM activities at the molecular and cellular levels. MCF7 cells were separately treated with 102 different molecules from TCMs, and their gene expression profiles were compared with the Connectivity Map (CMAP). To demonstrate the reliability and utility of our approach, we used nitidine chloride (NC) from the root of<jats:italic>Zanthoxylum nitidum<\/jats:italic>, a topoisomerase I\/II inhibitor and \u03b1-adrenoreceptor antagonist, as an example to study the molecular function of TCMs using CMAP data as references. We successfully applied this approach to the four ingredients in Danshen and analyzed the synergistic mechanism of TCM components. The results demonstrate that our newly generated TCM data and related methods are valuable in the analysis and discovery of the molecular actions of TCM components. This is the first work to establish gene expression profiles for the study of TCM components and serves as a template for general TCM research.<\/jats:p>","DOI":"10.1038\/s41598-017-00535-8","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T15:09:12Z","timestamp":1489763352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: a general template for research on TCMs"],"prefix":"10.1038","volume":"7","author":[{"given":"Chao","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-2876","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","volume":"13","author":"T Efferth","year":"2007","unstructured":"Efferth, T., Li, P. C. H., Konkimalla, V. S. B. & Kaina, B. From traditional Chinese medicine to rational cancer therapy. Trends. Mol. Med. 13, 353\u2013361 (2007).","journal-title":"Trends. Mol. Med."},{"key":"535_CR2","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1073\/pnas.0712365105","volume":"105","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. PNAS 105, 4826\u20134831 (2008).","journal-title":"PNAS"},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"45ra59","DOI":"10.1126\/scitranslmed.3001270","volume":"2","author":"W Lam","year":"2010","unstructured":"Lam, W. et al. The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity. Sci. Transl. Med. 2, 45ra59 (2010).","journal-title":"Sci. Transl. Med."},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","volume":"17","author":"XA Qu","year":"2012","unstructured":"Qu, X. A. & Rajpal, D. K. Applications of Connectivity Map in Drug Discovery and Development. Drug Discov. Today 17, 1289\u20131298 (2012).","journal-title":"Drug Discov. Today"},{"key":"535_CR5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb, J. The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7, 54\u201360 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"535_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","volume":"161","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Treatment of Obesity with Celastrol. Cell 161, 999\u20131011 (2015).","journal-title":"Cell"},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"e18278","DOI":"10.1371\/journal.pone.0018278","volume":"6","author":"Z Wen","year":"2011","unstructured":"Wen, Z. et al. Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map. PLoS One 6, e18278 (2011).","journal-title":"PLoS One"},{"key":"535_CR9","first-page":"1","volume":"14","author":"J Lin","year":"2013","unstructured":"Lin, J. et al. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 14, 1\u201311 (2013).","journal-title":"BMC Cancer"},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.fct.2014.01.049","volume":"66","author":"Z Fang","year":"2014","unstructured":"Fang, Z. et al. Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer. Food Chem. Toxicol. 66, 210\u2013216 (2014).","journal-title":"Food Chem. Toxicol."},{"key":"535_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2011.09.001","volume":"313","author":"X Pan","year":"2011","unstructured":"Pan, X. et al. Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src\/FAK associated signaling pathway. Cancer Lett. 313, 181\u2013191 (2011).","journal-title":"Cancer Lett."},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/bjc.1997.584","volume":"76","author":"M Ando","year":"1997","unstructured":"Ando, M. et al. Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non.small-cell lung cancer. Brit. J. Cancer. 76, 1494\u20131499 (1997).","journal-title":"Brit. J. Cancer."},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/S0021-9258(17)38654-4","volume":"260","author":"YH Hsiang","year":"1985","unstructured":"Hsiang, Y. H., Hertzberg, R., Hecht, S. & Liu, L. F. Camptothecin Induces Protein-linked DNA Breaks via Mammalian DNA Topoisomerase I. J. Biol. Chem. 260, 4873\u20134878 (1985).","journal-title":"J. Biol. Chem."},{"key":"535_CR14","first-page":"5969","volume":"49","author":"A Bodley","year":"1989","unstructured":"Bodley, A. et al. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res. 49, 5969\u20135978 (1989).","journal-title":"Cancer Res."},{"key":"535_CR15","first-page":"2795","volume":"56","author":"B Gatto","year":"1996","unstructured":"Gatto, B. et al. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. Cancer Res. 56, 2795\u20132800 (1996).","journal-title":"Cancer Res."},{"key":"535_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/0968-0896(96)00054-5","volume":"4","author":"D Makhey","year":"1996","unstructured":"Makhey, D. et al. Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons. Bioorgan. Med. Chem. 4, 781\u2013791 (1996).","journal-title":"Bioorgan. Med. Chem."},{"key":"535_CR17","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1016\/j.bmc.2004.04.038","volume":"12","author":"S Prado","year":"2004","unstructured":"Prado, S. et al. Synthesis and cytotoxic activity of benzo[c][1,7] and[1,8]phenanthrolines analogues of nitidine and fagaronine. Bioorgan. Med. Chem. 12, 3943\u20133953 (2004).","journal-title":"Bioorgan. Med. Chem."},{"key":"535_CR18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(25)30914-6","volume":"201","author":"RM Graham","year":"1977","unstructured":"Graham, R. M., Oates, H. F., Stoker, L. M. & Stokes, G. S. Alpha blocking action of the antihypertensive agent, prazosin. J. Pharmacol. Exp. Ther. 201, 747\u2013752 (1977).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jep.2014.01.033","volume":"152","author":"F Zhang","year":"2014","unstructured":"Zhang, F. et al. Chemical profile- and pharmacokinetics-based investigation of the synergistic property of Platycodonis Radix in Traditional Chinese Medicine formula Shengxian Decoction. J. Ethnopharmacol. 152, 497\u2013507 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1073\/pnas.0712365105","volume":"105","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. PNAS 105, 4826\u20134831 (2008).","journal-title":"PNAS"},{"key":"535_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-5-1","volume":"5","author":"S Li","year":"2011","unstructured":"Li, S., Zhang, B. & Zhang, N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst. Biol. 5, 1\u201313 (2011).","journal-title":"BMC Syst. Biol."},{"key":"535_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ijcard.2005.10.026","volume":"113","author":"TO Cheng","year":"2006","unstructured":"Cheng, T. O. Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease. Int J Cardiol. 113, 437\u2013438 (2006).","journal-title":"Int J Cardiol."},{"key":"535_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2007.01.004","volume":"121","author":"TO Cheng","year":"2007","unstructured":"Cheng, T. O. Cardiovascular effects of Danshen. Int. J. Cardiol. 121, 9\u201322 (2007).","journal-title":"Int. J. Cardiol."},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"e0124632","DOI":"10.1371\/journal.pone.0124632","volume":"10","author":"H Fang","year":"2015","unstructured":"Fang, H. et al. Analysis of Cynandione A\u2019s Anti-Ischemic Stroke Effects from Pathways and Protein-Protein Interactome. PLoS One 10, e0124632 (2015).","journal-title":"PLoS One"},{"key":"535_CR25","first-page":"391","volume":"2013","author":"H Fang","year":"2012","unstructured":"Fang, H. et al. Bioinformatics Analysis for the Antirheumatic Effects of Huang-Lian-Jie-Du-Tang from a Network Perspective. Evid-Based Compl. Alt. 2013, 391\u2013392 (2012).","journal-title":"Evid-Based Compl. Alt."},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ajhg.2008.02.013","volume":"82","author":"S K\u00f6hler","year":"2008","unstructured":"K\u00f6hler, S., Bauer, S., Horn, D. & Robinson, P. N. Walking the Interactome for Prioritization of Candidate Disease Genes. Am. J. Hum. Genet. 82, 949\u2013958 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"535_CR27","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1038\/srep06394","volume":"4","author":"KH Lee","year":"2014","unstructured":"Lee, K. H. et al. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine. Sci. Rep. 4, 6394\u20136394 (2014).","journal-title":"Sci. Rep."},{"key":"535_CR28","doi-asserted-by":"publisher","first-page":"e95004","DOI":"10.1371\/journal.pone.0095004","volume":"9","author":"X Li","year":"2014","unstructured":"Li, X. et al. A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action. PLoS One 9, e95004 (2014).","journal-title":"PLoS One"},{"key":"535_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.devcel.2010.06.014","volume":"19","author":"H Fang","year":"2010","unstructured":"Fang, H. et al. Transcriptome analysis of early organogenesis in human embryos. Dev. Cell. 19, 174\u2013184 (2010).","journal-title":"Dev. Cell."},{"key":"535_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2009.12.045","volume":"17","author":"K Wang","year":"2010","unstructured":"Wang, K. et al. PML\/RARalpha Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia. Cancer Cell 17, 186\u2013197 (2010).","journal-title":"Cancer Cell"},{"key":"535_CR31","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1182\/blood-2009-04-218123","volume":"114","author":"Z Li","year":"2009","unstructured":"Li, Z. et al. Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia. Blood 114, 4486\u20134493 (2009).","journal-title":"Blood"},{"key":"535_CR32","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1021\/jm300605m","volume":"55","author":"G Dong","year":"2012","unstructured":"Dong, G. et al. New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations. J. Med. Chem. 55, 7593\u20137613 (2012).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00535-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T01:12:16Z","timestamp":1750122736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00535-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-00535-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]},"assertion":[{"value":"25 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"352"}}